A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.